Scandinavian ChemoTech’s Animal Care Announces New Partnership
Scandinavian ChemoTech’s Animal Care proudly begins the third quarter of 2024 by securing a significant new order with The Woodlands Animal Cancer and Referral Center in Houston, Texas, one of the ten most populated cities in the USA. This order amounts to approximately USD 36,000 and marks another milestone in our commitment to advancing veterinary care.
The Woodlands Animal Cancer and Referral Center, one of the leading veterinary specialty hospitals in the Greater Houston area, has added our innovative vetIQure™ TSE system its state-of-the-art facility. This addition is a testament to their dedication to providing cutting-edge cancer treatment for dogs and cats.
The Woodlands Animal Cancer and Referral Center is leading the way in veterinary specialty care for dogs and cats with cancer in the Greater Houston area, Texas, United-States. Established five years ago in Pearland, the group expanded its services to The Woodlands in May 2023, becoming the first and only veterinary specialty referral hospital in the Houston area dedicated to dogs and cats with cancer, at the forefront of pioneering veterinary care.
“At The Woodlands, we pride ourselves on exceeding expectations and delivering the highest standards of patient care and referral services. Partnering with Animal Care’s vetIQure technology aligns perfectly with our mission to provide exceptional customer service and an unparalleled experience for our patients, clients, and referring veterinarians. The integration of the TSE Technology will enhance the overall experience at our clinic, offering a unique and patented solution for safe and effective tumor treatment while preserving healthy tissue,” said Dr. Melissa Parsons-Doherty, Founder and Veterinary Medical Oncologist at The Woodlands Animal Cancer and Referral Center.
Dr. Parsons-Doherty, a Diplomate of the American Veterinary Medical Association since 2013, hails from Canada. She earned her Doctor of Veterinary Medicine degree from the Atlantic Veterinary College in Prince Edward Island. Her extensive training includes a Rotating Internship in Medicine and Surgery at Garden State Veterinary Specialists in New Jersey, a Medical Oncology Internship at the University of Georgia, and a Residency in Medical Oncology at Louisiana State University.
"We are thrilled to continue expanding the reach of our TSE System to a broader range of patients and pet owners across the United States. Our partnership with The Woodlands Animal Cancer and Referral Center in Houston, Texas, represents a significant step forward for Animal Care in the Southern United States," said says Mohan Frick, CEO of ChemoTech
For further information please contact:
Mohan Frick, CEO
Phone: +46 (0)10-218 93 00
E-mail: ir@chemotech.se
Scandinavian ChemoTech AB (publ)
ChemoTech is a Swedish medical technology company based in Lund that has developed a patented technology platform to offer cancer patients access to a new treatment alternative, Tumour Specific Electroporation™ (TSE), available for treatment of both humans and animals. There are a large number of cancer patients whose tumours for various reasons cannot be treated by conventional methods but where TSE can be a solution. Therefore, the company continuously evaluates new opportunities and areas of application for the technology. ChemoTech's shares (CMOTEC B) are listed on Nasdaq First North Growth Market in Stockholm and Redeye AB is the company's Certified Adviser. Read more at: www.chemotech.se.
